Literature DB >> 4856785

Cyclophosphamide and hemorrhagic cystitis.

A H Bennett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4856785     DOI: 10.1016/s0022-5347(17)60025-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  7 in total

1.  Cytoxan and future sterility.

Authors:  C F Piel
Journal:  West J Med       Date:  1976-01

Review 2.  Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy: case report and literature review.

Authors:  Ruo-Qi Hu; Hashim Mehter; Tibor Nadasdy; Anjali Satoskar; Dan N Spetie; Brad H Rovin; Lee Hebert
Journal:  Rheumatol Int       Date:  2008-04-09       Impact factor: 2.631

3.  General adverse response to cyclophosphamide in Chinese patients with systemic autoimmune diseases in recent decade—a single-center retrospective study.

Authors:  Juan Li; Guowei Dai; Zhuoli Zhang
Journal:  Clin Rheumatol       Date:  2014-07-23       Impact factor: 2.980

Review 4.  Drug treatment of breast cancer.

Authors:  T E Davis; P P Carbone
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

Review 5.  Drug-induced bladder and urinary disorders. Incidence, prevention and management.

Authors:  M J Drake; P M Nixon; J P Crew
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606

6.  Double benefit of metformin treatment: improved bladder function in cyclophosphamide-induced cystitis and enhanced cytotoxicity in cancer cells.

Authors:  Seckin Engin; Elif Nur Barut; Aysun Celik Soysal; Oguzhan Keskin; Gokcen Kerimoglu; Mine Kadioglu; Sena Sezen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-29       Impact factor: 3.000

7.  Protective and therapeutic effect of hydrogen sulfide on hemorrhagic cystitis and testis dysfunction induced with cyclophosphamide

Authors:  Fikriye Yasemin Özatik; Orhan Özatik; Yasemin Tekşen; Semra Yiğitaslan; Neziha Senem Arı
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.